NASDAQ$MODVQ

Modivcare Inc · Q3 2025 earnings

Q3 2025 earnings · · Investor relations

Briefing

ModivCare reported Q3 2025, revenue of $679.7M, net loss of $50.4M.

For Q3 2025, ModivCare reported revenue of $679.7M, a net loss of $50.4M. Management discusses segment performance, capital allocation, and outlook in the earnings filing.

  • Revenue $679.7M.
  • Net loss $50.4M.
  • ModivCare highlights liquidity, operations, and 2026 priorities.

Headline financials

Total Revenue

$680M

Previous: $702M-3.2%
EPS (adj)

$14.00

Previous: -$1.87+848.7%
Capital Expenditures

-$16.9M

Previous: -$22.3M+24.2%
Free Cash Flow

-$172M

Previous: -$58.7M-192.3%
Net Income

-$73.1M

Previous: -$26.6M-174.9%
Operating Income

-$12.1M

Previous: $5.26M-329.4%
Gross Profit

$95.6M

Previous: $104M-8.2%

Revenue & EPS history

Modivcare · Revenue · Quarterly

$680M

Q3 2025-3.2%vs Q3 2024
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Forward guidance

The release discusses ModivCare's outlook for upcoming periods, including capital allocation, operating priorities, and market risks, without relying solely on numeric EPS bridges.

Tailwinds

  • ModivCare cites operational execution and demand trends supporting the outlook.
  • Balance sheet and liquidity actions aim to fund growth and returns.

Headwinds

  • GAAP profitability remained under pressure in Q3 2025.
  • Macro, pricing, and input-cost volatility could pressure margins.
  • Segment mix and one-time items may affect quarter-to-quarter comparability.
  • Clinical, regulatory, or liquidity milestones dominate the near-term outlook.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 6 quarterly earnings reports

Historical avg

+0.1%

Avg return

Earnings day

-10.6%

Avg return

5 days after

+29.9%

Avg return

30 days after

53%

33 / 62 earnings

Positive

+21.0%

Q1 2024

Best reaction

-41.0%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025
Q1 2025-11.4%-26.5%+198.5%
Q4 2024-22.5%-35.9%-68.1%
Q3 2024+10.6%-0.7%+11.3%
Q2 2024+15.8%+18.8%+59.8%
Q1 2024+21.0%+18.5%+23.0%
Q4 2023-41.0%-37.7%-44.9%
Q3 2023+14.5%
Q2 2023-4.4%
Q1 2023-21.6%
Q4 2022-1.6%
Q3 2022-5.9%
Q2 2022+2.0%
Q1 2022-7.2%
Q4 2021+16.5%
Q3 2021-8.8%
Q2 2021-1.2%
Q1 2021+2.0%
Q4 2020-15.4%
Q3 2020+4.1%
Q2 2020+8.8%
Q1 2020+7.9%
Q4 2019-9.2%
Q3 2019+5.2%
Q2 2019+2.6%
Q1 2019+2.3%
Q4 2018+0.1%
Q3 2018+11.4%
Q2 2018-9.3%
Q1 2018-6.3%
Q4 2017+7.6%
Q3 2017+5.2%
Q2 2017+0.0%
Q1 2017+10.3%
Q4 2016+8.8%
Q3 2016-7.0%
Q2 2016-1.7%
Q1 2016-0.8%
Q4 2015+16.3%
Q3 2015-14.6%
Q2 2015-0.8%
Q1 2015+12.2%
Q4 2014+9.9%
Q3 2014-11.3%
Q2 2014+17.8%
Q1 2014-2.7%
Q4 2013-10.4%
Q3 2013-11.7%
Q2 2013+0.7%
Q1 2013+6.7%
Q4 2012+5.1%
Q3 2012+16.4%
Q2 2012-14.7%
Q1 2011-0.9%
Q1 2012+0.6%
Q4 2009-2.2%
Q4 2011-2.2%
Q3 2010-2.3%
Q3 2011-2.3%
Q2 2011+4.3%
Q2 2010+4.3%
Q4 2010+4.3%
Q1 2010+1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro